These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34087130)

  • 1. Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer.
    Levy A; Le Péchoux C; Faivre-Finn C
    Lancet Oncol; 2021 Jun; 22(6):e220. PubMed ID: 34087130
    [No Abstract]   [Full Text] [Related]  

  • 2. Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer.
    Xie L; Fan X; Qian B
    Lancet Oncol; 2021 Jun; 22(6):e221. PubMed ID: 34087131
    [No Abstract]   [Full Text] [Related]  

  • 3. Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply.
    Grønberg BH; Langer SW; Nyman J; Halvorsen TO
    Lancet Oncol; 2021 Jun; 22(6):e222. PubMed ID: 34087132
    [No Abstract]   [Full Text] [Related]  

  • 4. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy 
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
    You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation 
with Concurrent Twice-daily Radiotherapy for Patients 
with Limited-stage Small Cell Lung Cancer].
    You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):55-60. PubMed ID: 28103974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter regarding "Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials".
    Li Z; Hu Y; Li Q
    Radiother Oncol; 2022 Dec; 177():243-244. PubMed ID: 36202197
    [No Abstract]   [Full Text] [Related]  

  • 7. In reply to Li et al. Letter to the editor. "Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.".
    Viani GA; Gouveia AG; Moraes FY
    Radiother Oncol; 2022 Dec; 177():245-246. PubMed ID: 36265684
    [No Abstract]   [Full Text] [Related]  

  • 8. Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review.
    Yamamoto Y; Shibahara D; Mori T; Otsubo K; Shiraishi Y; Yoneshima Y; Iwama E; Tanaka K; Oda Y; Okamoto I
    Thorac Cancer; 2024 May; 15(13):1106-1111. PubMed ID: 38528720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based Results of Chemoradiotherapy for Limited Stage Small Cell Lung Cancer in The Netherlands.
    Damhuis R; Widder J; Senan S
    Clin Oncol (R Coll Radiol); 2018 Jan; 30(1):17-22. PubMed ID: 29102167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent dermatophytosis (Majocchi granuloma) associated with chemotherapy-induced neutropenia.
    Lourdes LS; Mitchell CL; Glavin FL; Schain DC; Kaye FJ
    J Clin Oncol; 2014 Sep; 32(27):e92-4. PubMed ID: 24470005
    [No Abstract]   [Full Text] [Related]  

  • 11. [Concurrent once-daily or twice-daily chemoradiotherapy in limited-stage small-cell lung cancer?].
    Frosch S; Troost EGC
    Strahlenther Onkol; 2018 Jan; 194(1):73-75. PubMed ID: 29143097
    [No Abstract]   [Full Text] [Related]  

  • 12. Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
    Morimoto M; Okishio K; Akira M; Omachi N; Tamiya A; Asami K; Kawaguchi T; Atagi S
    Clin Lung Cancer; 2017 Mar; 18(2):e117-e127. PubMed ID: 28340925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
    Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
    Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
    Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of small cell lung cancer treated with chemoradiotherapy followed by photodynamic therapy.
    Lee JE; Park HS; Jung SS; Kim SY; Kim JO
    Thorax; 2009 Jul; 64(7):637-9. PubMed ID: 19561284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal lung tumor volume changes in small-cell lung cancer patients undergoing chemoradiotherapy.
    Yee D; Rathee S; Robinson D; Murray B
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):142-7. PubMed ID: 20646851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study.
    Lecumberri R; López Vivanco G; Font A; González Billalabeitia E; Gúrpide A; Gómez Codina J; Isla D; Galán A; Bover I; Domine M; Vicente V; Rosell R; Rocha E
    Thromb Res; 2013; 132(6):666-70. PubMed ID: 24491267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited-stage small cell lung cancer to definitive chemoradiotherapy.
    Li L; Duan J; Gao Y; Yin Y; Yang F; Tang W; Song X; Hu T; Cui J; Yu J; Yuan S
    Clin Transl Med; 2024 Jan; 14(1):e1522. PubMed ID: 38193621
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study.
    Senan S; Okamoto I; Lee GW; Chen Y; Niho S; Mak G; Yao W; Shire N; Jiang H; Cho BC
    Clin Lung Cancer; 2020 Mar; 21(2):e84-e88. PubMed ID: 31948903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II Study of Consolidation Amrubicin After Concurrent Chemoradiotherapy in Patients With Limited-stage Small-cell Lung Cancer.
    Yoshida H; Nagai H; Sakamori Y; Ozasa H; Nishimura T; Tomii K; Hirai T; Matsuo Y; Iizuka Y; Mizowaki T; Yoshimura K; Kim YH
    In Vivo; 2020; 34(2):897-902. PubMed ID: 32111801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.